{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:52:07Z","timestamp":1790736727761,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UG1 HD054241, UG1 HD041261, UG1 HD054214, UG1 HD041267, UG1 HD069010, UG1 HD069006, UG1 HD069013, U24 HD069031"],"award-info":[{"award-number":["UG1 HD054241, UG1 HD041261, UG1 HD054214, UG1 HD041267, UG1 HD069010, UG1 HD069006, UG1 HD069013, U24 HD069031"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00192-020-04271-y","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T11:02:40Z","timestamp":1583578960000},"page":"2155-2164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Outcomes of native tissue transvaginal apical approaches in women with advanced pelvic organ prolapse and stress urinary incontinence"],"prefix":"10.1007","volume":"31","author":[{"name":"on behalf of the NICHD Pelvic Floor Disorders Network and the National Institutes of Health Office of Research on Women\u2019s Health","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1425-9614","authenticated-orcid":false,"given":"Isuzu","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan E.","family":"Whitworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Lukacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian W.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G.","family":"Visco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Ackenbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford Y.","family":"Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Mazloomdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie G.","family":"Gantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly E.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,7]]},"reference":[{"key":"4271_CR1","volume-title":"Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal mesh placement for pelvic organ prolapse","author":"FDA","year":"2011","unstructured":"FDA. Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal mesh placement for pelvic organ prolapse. Washington, DC: US Food and Drug Administration; 2011."},{"issue":"1","key":"4271_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1067\/mob.2003.101","volume":"188","author":"SH Boyles","year":"2003","unstructured":"Boyles SH, Weber AM, Meyn L. Procedures for pelvic organ prolapse in the United States, 1979\u20131997. Am J Obstet Gynecol. 2003;188(1):108\u201315.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"4271_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/SPV.0b013e3182713ccc","volume":"18","author":"TI Montoya","year":"2012","unstructured":"Montoya TI, Grande KB, Rahn DD. Apical vaginal prolapse surgery: practice patterns and factors guiding route of repair. Female Pelvic Med Reconstr Surg. 2012;18(6):315\u201320.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"1","key":"4271_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/AOG.0000000000000057","volume":"123","author":"JM Wu","year":"2014","unstructured":"Wu JM, et al. Prevalence and trends of symptomatic pelvic floor disorders in US women. Obstet Gynecol. 2014;123(1):141\u20138.","journal-title":"Obstet Gynecol"},{"key":"4271_CR5","doi-asserted-by":"crossref","unstructured":"Denman MA, et al. Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol. 2008;198(5):555 e1\u20135.","DOI":"10.1016\/j.ajog.2008.01.051"},{"issue":"2","key":"4271_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ajog.2009.07.052","volume":"202","author":"RU Margulies","year":"2010","unstructured":"Margulies RU, Rogers MA, Morgan DM. Outcomes of transvaginal uterosacral ligament suspension: systematic review and metaanalysis. Am J Obstet Gynecol. 2010;202(2):124\u201334.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"4271_CR7","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.ajog.2004.06.109","volume":"191","author":"JL Whiteside","year":"2004","unstructured":"Whiteside JL, et al. Risk factors for prolapse recurrence after vaginal repair. Am J Obstet Gynecol. 2004;191(5):1533\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"4271_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00404-012-2685-8","volume":"287","author":"A Qatawneh","year":"2013","unstructured":"Qatawneh A, et al. Risk factors of surgical failure following sacrospinous colpopexy for the treatment of uterovaginal prolapse. Arch Gynecol Obstet. 2013;287(6):1159\u201365.","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"4271_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1001\/jama.2014.1719","volume":"311","author":"MD Barber","year":"2014","unstructured":"Barber MD, et al. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA. 2014;311(10):1023\u201334.","journal-title":"JAMA"},{"issue":"2","key":"4271_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cct.2008.12.001","volume":"30","author":"MD Barber","year":"2009","unstructured":"Barber MD, et al. Operations and pelvic muscle training in the management of apical support loss (OPTIMAL) trial: design and methods. Contemp Clin Trials. 2009;30(2):178\u201389.","journal-title":"Contemp Clin Trials"},{"issue":"6","key":"4271_CR11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1067\/mob.2001.118659","volume":"185","author":"MD Barber","year":"2001","unstructured":"Barber MD, et al. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol. 2001;185(6):1388\u201395.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"4271_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","volume":"193","author":"MD Barber","year":"2005","unstructured":"Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193(1):103\u201313.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"4271_CR13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/AOG.0b013e3181b2b1ae","volume":"114","author":"MD Barber","year":"2009","unstructured":"Barber MD, et al. Defining success after surgery for pelvic organ prolapse. Obstet Gynecol. 2009;114(3):600\u20139.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"4271_CR14","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00192-008-0678-8","volume":"19","author":"MF Fialkow","year":"2008","unstructured":"Fialkow MF, Newton KM, Weiss NS. Incidence of recurrent pelvic organ prolapse 10 years following primary surgical management: a retrospective cohort study. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(11):1483\u20137.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"6","key":"4271_CR15","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1097\/01.AOG.0000264066.89094.21","volume":"109","author":"DM Morgan","year":"2007","unstructured":"Morgan DM, et al. Heterogeneity in anatomic outcome of sacrospinous ligament fixation for prolapse: a systematic review. Obstet Gynecol. 2007;109(6):1424\u201333.","journal-title":"Obstet Gynecol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04271-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-020-04271-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04271-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:52:49Z","timestamp":1615078369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-020-04271-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,7]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4271"],"URL":"https:\/\/doi.org\/10.1007\/s00192-020-04271-y","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,7]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"I Meyer, RE Whitworth, AL Smith, VW Sung, MF Ackenbom, C Wai: No conflict of interest.ES Lukacz: Research Support: Boston Scientific, Uroplasty\/Cogentix, Pfizer; Consultant: Axonics.AG Visco: Stock ownership: NinoMed.D Mazloomdoost: Research Grant: Boston Scientific.MG Gantz: Research Grant: Boston Scientific.HE Richter: Research Grant: Renovia, Allergan;","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}